Mucopolysaccharidoses: Clinical features and diagnosis and Enzyme Replacement Therapy

LANGUAGE AND DURATION

Language: English
Duration: 37 minutes, followed by questions from the audience

PRESENTER

Presenter: Prof. Florian Lagler, Paracelsus Medical University in Salzburg, Austria

LEARNING OBJECTIVES

An overview of typical features of different forms of Mucopolysaccharidoses.
Understanding the challenges in interdisciplinary management of MPS patients.
Understanding the potential and limitations of enzyme replacement therapy.

COURSE DESCRIPTION

Misdiagnosis of Mucopolysaccharidosis (MPS) results in late diagnosis and the late start of treatment, which has significant consequences on long-term outcomes. This gap usually results in confusing symptoms with other conditions, most notably trying to address symptoms directly and delaying actual diagnosis and treatment or referring the patient to the wrong pediatric specialties, causing further delays in the condition’s management chain.

The Spot the Early Signs program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients.

AUDIENCE

This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Endocrinologists, Pediatric Rheumatologists, and other physicians and healthcare professionals interested in Metabolic Diseases.